213 related articles for article (PubMed ID: 24218296)
41. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
42. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
Theilade S; Hansen TW; Rossing P
Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for progression of renal disease in patient with diabetic nephropathy.
Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
[TBL] [Abstract][Full Text] [Related]
44. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
Bruce R; Williams L; Cundy T
Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
[TBL] [Abstract][Full Text] [Related]
45. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
[TBL] [Abstract][Full Text] [Related]
46. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
Berglund J
Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
[TBL] [Abstract][Full Text] [Related]
47. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
[TBL] [Abstract][Full Text] [Related]
48. [Natural history of nephropathy in type I diabetes mellitus].
Esmatjes E; Gutiérrez A; Goday A; Novials A; Ricart MJ; González MT; García M; Ríos M; Figuerola D
Med Clin (Barc); 1988 Jan; 90(2):47-9. PubMed ID: 3347113
[No Abstract] [Full Text] [Related]
49. Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.
Skupien J; Warram JH; Niewczas MA; Gohda T; Malecki M; Mychaleckyj JC; Galecki AT; Krolewski AS
Diabetes Care; 2014 Sep; 37(9):2601-8. PubMed ID: 24898299
[TBL] [Abstract][Full Text] [Related]
50. Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.
Bentata Y; Haddiya I; Latrech H; Serraj K; Abouqal R
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):392-402. PubMed ID: 23538374
[TBL] [Abstract][Full Text] [Related]
51. Diabetic nephropathy in patients with type 1 diabetes mellitus.
Russell TA
Nephrol Nurs J; 2006; 33(1):15-28; quiz 29-30. PubMed ID: 16538925
[TBL] [Abstract][Full Text] [Related]
52. Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.
Pilemann-Lyberg S; Rasmussen DGK; Hansen TW; Tofte N; Winther SA; Holm Nielsen S; Theilade S; Karsdal MA; Genovese F; Rossing P
Diabetes Care; 2019 Sep; 42(9):1760-1768. PubMed ID: 31262950
[TBL] [Abstract][Full Text] [Related]
53. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
Conti AA
Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
[TBL] [Abstract][Full Text] [Related]
54. Diabetes-related end-stage renal disease in Austria 1965-2013.
Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
[TBL] [Abstract][Full Text] [Related]
55. Improved prognosis of diabetic nephropathy in type 1 diabetes.
Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Hovind P; Hansen TW; Rossing P
Kidney Int; 2015 Feb; 87(2):417-26. PubMed ID: 24918158
[TBL] [Abstract][Full Text] [Related]
56. [Diabetic nephropathy. Pathogenetic, diagnostic and therapeutic concepts].
Kleophas W; Voitz T; Messner H; Gries FA
Fortschr Med; 1990 May; 108(16):309-12. PubMed ID: 2204599
[TBL] [Abstract][Full Text] [Related]
57. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
[TBL] [Abstract][Full Text] [Related]
58. Morphologic features of declining renal function in type 1 diabetes.
Najafian B; Mauer M
Semin Nephrol; 2012 Sep; 32(5):415-22. PubMed ID: 23062981
[TBL] [Abstract][Full Text] [Related]
59. Should there be an expanded role for kidney biopsy in the management of patients with type I diabetes?
Mauer SM; Chavers BM; Steffes MW
Am J Kidney Dis; 1990 Aug; 16(2):96-100. PubMed ID: 2382660
[TBL] [Abstract][Full Text] [Related]
60. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
